The Application of Plasma 1,5-Anhydro-D-glucitol for Monitoring Type 2 Diabetic Patients | Zendy

Marzena Dworacka | Zendy; Hanna Winiarska | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Application of Plasma 1,5-Anhydro-D-glucitol for Monitoring Type 2 Diabetic Patients

Author(s) -

Marzena Dworacka,

Hanna Winiarska

Publication year - 2005

Publication title -

disease markers

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.912

H-Index - 66

eISSN - 1875-8630

pISSN - 0278-0240

DOI - 10.1155/2005/251068

Subject(s) - postprandial , medicine , type 2 diabetes , plasma glucose , diabetes mellitus , endocrinology , multivariate analysis , gastroenterology

Recent data have suggested that effective control of postprandial blood glucose can reduce the risk of macroangiopathic complications of diabetes, especially cardiovascular risk. 1,5-Anhydro-D-glucitol (1,5-AG) has been proposed as a marker of short-term hyperglycaemic excursions. We aimed to evaluate its usefulness in patients with type 2 diabetes and have attempted to indicate when 1,5-AG monitoring should be used in ordinary diabetes care settings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research